VTRS | Viatris

11.20 -0.42 (-3.61%)

VTRS Price Profile

Open

$11.43

CLOSE

$11.20

DAY RANGE

11.14 - 11.46

52 WEEK RANGE

9.66 - 15.92

MARKET CAP

17.68B

Trading volume

8.02M

Prev. Close

11.62

50 Day MA

13.57

Shares Outstanding

1.21B

Public Float

1.21B

Average Volume

8.47M

Beta

1.45

PEG Ratio

-11.29

Shares Shorted

19.99M

% OF SHARES SHORTED

1.86%

Short Ratio

1.95

1 Year Performance

-14.60%

Diluted EPS (TTM)

-1.72

Q Revenue Growth

0.53

Ebitda

5.47B

Gross Profit (TTM)

4.78B

Total Cash (MRQ)

844.3M

Total Debt (MRQ)

23.74B

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Viatris (VTRS) company profile

Viatris Inc. (NASDAQ: VTRS) is a healthcare company that develops, licenses, manufactures, markets, and distributes generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients. Some of the company’s popular markets include the Developed Markets, Greater China, JANZ, and Emerging Markets segments. The company’s drugs focus on infectious diseases and non-communicable diseases.

Latest VTRS News

AD